Free Trial

Trevi Therapeutics (TRVI) Short Interest Ratio & Short Volume

Trevi Therapeutics logo
$2.94
-0.12 (-3.92%)
(As of 10/31/2024 ET)

Trevi Therapeutics Short Interest Data

Trevi Therapeutics (TRVI) has a short interest of 1.52 million shares. This marks a 0.66% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.6, indicating that it would take 4.6 days of the average trading volume of 280,815 shares to cover all short positions.

Current Short Interest
1,520,000 shares
Previous Short Interest
1,510,000 shares
Change Vs. Previous Month
+0.66%
Dollar Volume Sold Short
$4.83 million
Short Interest Ratio
4.6 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
72,592,000 shares
Percentage of Shares Shorted
2.09%
Today's Trading Volume
231,497 shares
Average Trading Volume
280,815 shares
Today's Volume Vs. Average
82%
Short Selling Trevi Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Trevi Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TRVI Short Interest Over Time

TRVI Days to Cover Over Time

TRVI Percentage of Float Shorted Over Time

Trevi Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/20241,520,000 shares $4.83 million +0.7%N/A4.6 $3.18
9/30/20241,510,000 shares $5.04 million +8.6%N/A5.7 $3.34
9/15/20241,390,000 shares $4.68 million -10.3%N/A5.4 $3.37
8/31/20241,550,000 shares $4.90 million +3.3%N/A6.8 $3.16
8/15/20241,500,000 shares $4.13 million +16.3%N/A6.6 $2.75
7/31/20241,290,000 shares $4.10 million +1.6%N/A5.6 $3.18
7/15/20241,270,000 shares $3.62 million +32.6%N/A5.6 $2.85
6/30/2024957,600 shares $2.85 million -0.4%N/A4.4 $2.98
6/15/2024961,000 shares $2.55 million +13.1%N/A4.8 $2.65
5/31/2024849,600 shares $2.18 million -13.9%N/A4 $2.57
5/15/2024986,400 shares $2.73 million -6.1%N/A4.2 $2.77
4/30/20241,050,000 shares $3.08 million +16.9%N/A3.6 $2.93
4/15/2024898,400 shares $2.52 million -13.6%N/A3 $2.81
3/31/20241,040,000 shares $3.59 million -2.8%N/A3.5 $3.45
3/15/20241,070,000 shares $3.58 million -13.7%N/A3.8 $3.35
2/29/20241,240,000 shares $3.62 million +4.2%N/A4.2 $2.92
2/15/20241,190,000 shares $2.83 million -13.8%N/A2.7 $2.38
1/31/20241,380,000 shares $1.96 million +11.3%N/A3.6 $1.42
1/15/20241,240,000 shares $1.76 million +6.0%N/A3.2 $1.42
12/31/20231,170,000 shares $1.57 million +15.8%N/A3.1 $1.34
12/15/20231,010,000 shares $1.29 million -7.3%N/A2.8 $1.28
11/30/20231,090,000 shares $1.23 million -4.4%N/A3.4 $1.13
11/15/20231,140,000 shares $1.57 million -1.7%N/A6.4 $1.38
10/31/20231,160,000 shares $2.06 million -4.9%N/A14 $1.78
10/15/20231,220,000 shares $2.48 million -3.2%N/A18.8 $2.03
9/30/20231,260,000 shares $2.75 million -4.6%N/A17.5 $2.18
9/15/20231,320,000 shares $3.10 million +0.8%N/A14.1 $2.35
8/31/20231,310,000 shares $2.90 million -3.7%N/A6.5 $2.21
8/15/20231,360,000 shares $3.29 million +3.0%N/A4.1 $2.42
7/31/20231,320,000 shares $3.14 million +1.5%N/A3.6 $2.38
7/15/20231,300,000 shares $2.81 million -2.3%N/A3.3 $2.16
6/30/20231,330,000 shares $3.18 million +482.8%N/A3.5 $2.39
6/15/2023228,200 shares $588,756.00 -5.9%N/A0.6 $2.58
5/31/2023242,600 shares $524,016.00 -2.1%N/A1 $2.16
5/15/2023247,900 shares $654,456.00 -11.6%N/A1.5 $2.64
4/30/2023280,300 shares $964,232.00 +39.2%N/A3.4 $3.44
4/15/2023201,300 shares $380,457.00 +15.4%N/A3.2 $1.89
3/31/2023174,400 shares $322,640.00 +51.9%N/A3.6 $1.85
3/15/2023114,800 shares $210,084.00 +73.2%N/A1.1 $1.83
2/28/202366,300 shares $158,457.00 -15.8%N/A0.6 $2.39
The real reason Elon is fully endorsing Trump (Ad)

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.

Watch this new documentary and you’ll discover what Elon knows,
2/15/202378,700 shares $201,472.00 -11.6%N/A0.7 $2.56
1/31/202389,000 shares $207,370.00 -7.0%N/A0.8 $2.33
1/15/202395,700 shares $250,734.00 +0.8%N/A0.8 $2.62
12/30/202294,900 shares $183,157.00 -40.6%N/A0.7 $1.93
12/15/2022159,800 shares $356,354.00 -34.2%N/A0.8 $2.23
11/30/2022242,800 shares $456,464.00 -16.3%N/A1.2 $1.88
11/15/2022289,900 shares $637,780.00 -1.9%N/A1.2 $2.20
10/31/2022295,600 shares $585,288.00 -27.0%N/A1.1 $1.98
10/15/2022405,100 shares $725,129.00 +264.0%N/A1.3 $1.79
9/30/2022111,300 shares $171,402.00 +12.5%N/A0.3 $1.54
9/15/202298,900 shares $306,590.00 -9.9%N/A0.1 $3.10
8/31/2022109,700 shares $348,846.00 -2.3%0.6%0.1 $3.18
8/15/2022112,300 shares $424,494.00 -19.1%0.6%0.1 $3.78
7/31/2022138,800 shares $424,728.00 -29.9%1.1%0.1 $3.06
7/15/2022198,100 shares $691,369.00 +99.3%1.5%0.1 $3.49
6/30/202299,400 shares $279,314.00 +10.3%0.8%0.1 $2.81
6/15/202290,100 shares $199,121.00 -29.7%0.8%0.1 $2.21
5/31/2022128,100 shares $310,002.00 -48.5%1.1%0.2 $2.42
5/15/2022248,800 shares $549,848.00 -37.4%2.2%0.2 $2.21
4/30/2022397,500 shares $1.07 million -27.6%11.7%0.3 $2.70
4/15/2022548,900 shares $1.80 million +66.6%3.9%0.5 $3.28
3/31/2022329,400 shares $724,680.00 -60.4%2.3%0.3 $2.20
3/15/2022832,300 shares $1.22 million +40.9%N/A1.3 $1.46
2/28/2022590,800 shares $378,112.00 +286.9%4.5%1 $0.64
2/15/2022152,700 shares $79,251.30 +95.5%1.2%0.6 $0.52
1/31/202278,100 shares $49,804.37 +4.3%0.8%0.3 $0.64
1/15/202274,900 shares $53,830.63 -34.9%0.8%0.3 $0.72
12/31/2021115,100 shares $90,031.22 +16.6%1.2%0.2 $0.78
12/15/202198,700 shares $70,767.90 +16.7%1.0%0.2 $0.72
11/30/202184,600 shares $84,143.16 -42.2%1.2%0.2 $0.99
11/15/2021146,400 shares $161,040.00 -8.3%2.1%0.3 $1.10
10/29/2021159,700 shares $187,647.50 +14.3%2.8%0.4 $1.18
10/15/2021139,700 shares $180,213.00 +25.9%2.4%0.4 $1.29
9/30/2021111,000 shares $155,400.00 +26.1%1.5%0.4 $1.40
9/15/202188,000 shares $123,200.00 +43.1%1.2%1.5 $1.40
8/31/202161,500 shares $102,090.00 -23.8%0.8%0.8 $1.66
8/13/202180,700 shares $162,610.50 +11.3%1.1%1.2 $2.02
7/30/202172,500 shares $137,750.00 -28.0%1.1%1.1 $1.90
7/15/2021100,700 shares $196,365.00 +16.7%1.6%1.4 $1.95
6/30/202186,300 shares $194,175.00 -1.9%1.3%1.3 $2.25
6/15/202188,000 shares $196,240.00 -6.1%1.5%1.5 $2.23
5/28/202193,700 shares $199,581.00 +11.7%1.6%2.5 $2.13
5/14/202183,900 shares $168,639.00 +36.0%1.4%1.8 $2.01
4/30/202161,700 shares $144,995.00 -30.6%1.0%1 $2.35
4/15/202188,900 shares $221,805.50 +31.7%1.5%1 $2.50
3/31/202167,500 shares $193,050.00 -46.5%1.4%0.7 $2.86
3/15/2021126,200 shares $340,740.00 +132.4%2.9%1.1 $2.70
2/26/202154,300 shares $155,298.00 -16.3%1.2%0.5 $2.86
2/12/202164,900 shares $205,733.00 +2.0%1.5%0.6 $3.17
1/29/202163,600 shares $192,708.00 +35.6%1.5%0.7 $3.03
Banking failure dead ahead (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

1/15/202146,900 shares $140,700.00 +4.9%1.1%0.7 $3.00
12/31/202044,700 shares $113,538.00 -0.9%1.0%1 $2.54
12/15/202045,100 shares $132,143.00 +14.5%1.1%1.3 $2.93
11/30/202039,400 shares $121,549.00 -12.4%0.9%1.7 $3.09
11/15/202045,000 shares $151,200.00 -5.9%1.6%1.6 $3.36
10/30/202047,800 shares $152,004.00 +13.8%1.7%1.1 $3.18
10/15/202042,000 shares $153,300.00 -40.8%1.5%0.5 $3.65
9/30/202070,900 shares $285,727.00 -9.6%2.5%0.8 $4.03
9/15/202078,400 shares $301,840.00 +185.1%2.7%0.8 $3.85
8/31/202027,500 shares $110,825.00 -67.1%1.0%0.3 $4.03
8/14/202083,700 shares $490,482.00 +65.7%3.3%0.6 $5.86
7/31/202050,500 shares $250,985.00 +18.5%1.9%0.4 $4.97
7/15/202042,600 shares $218,964.00 -29.9%1.6%0.5 $5.14
6/30/202060,800 shares $417,696.00 +1.8%2.4%0.7 $6.87
6/15/202059,700 shares $271,038.00 +7,362.5%2.3%0.5 $4.54
5/29/2020800 shares $2,216.00 -97.1%0.0%0 $2.77
5/15/202027,800 shares $77,840.00 +1.5%1.1%0.4 $2.80
4/30/202027,400 shares $78,364.00 +1,342.1%1.1%0.4 $2.86
4/15/20201,900 shares $5,424.50 -77.9%0.1%0 $2.86
3/31/20208,600 shares $24,768.00 +126.3%0.3%0.1 $2.88
3/13/20203,800 shares $10,260.00 +18.8%0.2%1.8 $2.70
2/28/20203,200 shares $7,552.00 -13.5%0.1%0.4 $2.36
2/14/20203,700 shares $14,430.00 -48.6%0.1%0.4 $3.90
1/31/20207,200 shares $41,760.00 -72.4%0.3%0.7 $5.80
1/15/202026,100 shares $136,242.00 -30.4%1.0%1.9 $5.22
12/31/201937,500 shares $194,250.00 +72.8%1.5%2.7 $5.18

TRVI Short Interest - Frequently Asked Questions

What is Trevi Therapeutics' current short interest?

Short interest is the volume of Trevi Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 1,520,000 shares of TRVI short. Learn More on Trevi Therapeutics' current short interest.

What is a good short interest ratio for Trevi Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TRVI shares currently have a short interest ratio of 5.0. Learn More on Trevi Therapeutics's short interest ratio.

Is Trevi Therapeutics' short interest increasing or decreasing?

Trevi Therapeutics saw a increase in short interest in October. As of October 15th, there was short interest totaling 1,520,000 shares, an increase of 0.7% from the previous total of 1,510,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Trevi Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Trevi Therapeutics: Vanda Pharmaceuticals Inc. (7.21%), VYNE Therapeutics Inc. (0.39%), Cara Therapeutics, Inc. (1.33%), Pliant Therapeutics, Inc. (11.43%), Tyra Biosciences, Inc. (8.25%), AnaptysBio, Inc. (23.16%), Sana Biotechnology, Inc. (27.36%), Cronos Group Inc. (2.46%), Dianthus Therapeutics, Inc. (23.56%), Annexon, Inc. (8.44%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Trevi Therapeutics stock?

Short selling TRVI is an investing strategy that aims to generate trading profit from Trevi Therapeutics as its price is falling. TRVI shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Trevi Therapeutics?

A short squeeze for Trevi Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TRVI, which in turn drives the price of the stock up even further.

How often is Trevi Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRVI, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:TRVI) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners